Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platinum complexes with anticancer potential and their evaluation by a colorimetric lambda prophage induction assay.

B Das Sarma, S K Daley, R K Elespuru

    Chemico-Biological Interactions
    |September 1, 1983
    PubMed
    Summary

    A biochemical phage induction assay (BIA) effectively screened platinum antitumor compounds, identifying active agents and inactive analogs. This rapid, inexpensive method aids in studying structure-activity relationships for novel platinum drug development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology.

    Lymphology·2020
    Same author

    Radioprotection from radiation-induced lymphedema without tumor protection.

    Lymphology·2010
    Same author

    New approaches to assessing the effects of mutagenic agents on the integrity of the human genome.

    Mutation research·2006
    Same author

    Future approaches to genetic toxicology risk assessment.

    Mutation research·1996
    Same author

    Photoactivated gilvocarcin V induces DNA-protein crosslinking in genes for human ribosomal RNA and dihydrofolate reductase.

    Photochemistry and photobiology·1994
    Same author

    Examination of alpha-carbonyl derivatives of nitrosodimethylamine and ethylnitrosomethylamine as putative proximate carcinogens.

    Carcinogenesis·1993

    Area of Science:

    • Biochemistry
    • Medicinal Chemistry
    • Pharmacology

    Background:

    • Platinum-based compounds are crucial in cancer chemotherapy.
    • Developing novel platinum analogs requires efficient screening methods.
    • Predicting in vivo activity from in vitro assays is challenging.

    Purpose of the Study:

    • To evaluate a biochemical phage induction assay (BIA) for screening antitumor platinum compounds.
    • To assess the assay's ability to establish structure-activity relationships.
    • To compare the BIA's predictions with in vivo antitumor activity.

    Main Methods:

    • A biochemical phage induction assay (BIA) was employed.
    • Fifty-three platinum complexes, including novel ethylenediamines, were tested.

    Related Experiment Videos

  • Activity was assessed for platinum, palladium(II), and Pt(II) cationic complexes.

    • Main Results:

    • The BIA showed significant activity for 90% of tested antitumor platinum compounds.
    • All palladium(II) compounds and Pt(II) cationic complexes showed no activity, as expected.
    • Activity magnitude varied, reflecting structural differences, and seven platinum complexes exceeded cisplatin's activity.

    Conclusions:

    • The BIA is a simple, rapid, inexpensive, and quantitative method for screening platinum antitumor compounds.
    • The assay effectively establishes structure-activity relationships for platinum analogs.
    • The BIA accurately predicted high or low in vivo activity but not intermediate levels.